Brief: Rakovina Therapeutics - Receives Notice Of Allowance For New U.S. Patent Covering KT-2000 Series Parp Inhibitors
07/10/2021 14:13
Oct 7 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS - RECEIVES NOTICE OF ALLOWANCE FOR
NEW
U.S. PATENT COVERING KT-2000 SERIES PARP INHIBITORS
Source text for Eikon: ID:nGNXc2SYSD
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration